Skip to main content
. 2021 Dec 10;19(12):e06955. doi: 10.2903/j.efsa.2021.6955

Figure 10.

Figure 10

Proportion (%) of non‐susceptible clinical Escherichia coli isolates from cattle digestive cases for nine antimicrobials of interest reported by the RESAPATH monitoring programme